BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16863787)

  • 1. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms.
    Ostrow AM; Freeze H; Rychik J
    Ann Thorac Surg; 2006 Aug; 82(2):695-700. PubMed ID: 16863787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-losing enteropathy after Fontan operation.
    Rychik J
    Congenit Heart Dis; 2007; 2(5):288-300. PubMed ID: 18377444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation.
    Thacker D; Patel A; Dodds K; Goldberg DJ; Semeao E; Rychik J
    Ann Thorac Surg; 2010 Mar; 89(3):837-42. PubMed ID: 20172140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to treat protein-losing enteropathy.
    Rychik J; Spray TL
    Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():3-11. PubMed ID: 11994860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Impact of Fontan Operation on Enteric Protein Loss.
    Patel JK; Loomes KM; Goldberg DJ; Mercer-Rosa L; Dodds K; Rychik J
    Ann Thorac Surg; 2016 Mar; 101(3):1025-30. PubMed ID: 26652137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-losing enteropathy after fontan surgery: is assessment of risk patients with immunological data possible?
    Lenz D; Hambsch J; Schneider P; Tárnok A
    Cytometry B Clin Cytom; 2003 May; 53(1):34-9. PubMed ID: 12717689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.
    Ohuchi H; Yasuda K; Miyazaki A; Kitano M; Sakaguchi H; Yazaki S; Tsuda E; Yamada O
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):e49-57. PubMed ID: 23396878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
    Uzun O; Wong JK; Bhole V; Stumper O
    Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation.
    John AS; Driscoll DJ; Warnes CA; Phillips SD; Cetta F
    Ann Thorac Surg; 2011 Oct; 92(4):1451-6. PubMed ID: 21784410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic oxygen saturation and coagulation factor abnormalities before and after the fontan procedure.
    Cheung EW; Chay GW; Ma ES; Cheung YF
    Am J Cardiol; 2005 Dec; 96(11):1571-5. PubMed ID: 16310443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low pulmonary vascular compliance predisposes post-Fontan patients to protein-losing enteropathy.
    Yu JJ; Yun TJ; Yun SC; Im YM; Lee SC; Shin HJ; Ko HK; Park JJ; Seo DM; Kim YH; Ko JK; Park IS
    Int J Cardiol; 2013 May; 165(3):454-7. PubMed ID: 21944467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
    Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.
    Breatnach CR; Cleary A; Prendiville T; Crumlish K; Murchan H; McMahon CJ
    Pediatr Cardiol; 2018 Jan; 39(1):33-37. PubMed ID: 28879464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis.
    Schumacher KR; Gossett J; Guleserian K; Naftel DC; Pruitt E; Dodd D; Carboni M; Lamour J; Pophal S; Zamberlan M; Gajarski RJ
    J Heart Lung Transplant; 2015 Sep; 34(9):1169-76. PubMed ID: 25987313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation.
    Vyas H; Driscoll DJ; Cetta F; Loftus CG; Connolly HM
    Am J Cardiol; 2006 Sep; 98(5):666-7. PubMed ID: 16923458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation.
    Kim SJ; Park IS; Song JY; Lee JY; Shim WS
    Ann Thorac Surg; 2004 Apr; 77(4):1456-7. PubMed ID: 15063295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and improved survival in patients with protein-losing enteropathy after the Fontan operation.
    John AS; Johnson JA; Khan M; Driscoll DJ; Warnes CA; Cetta F
    J Am Coll Cardiol; 2014 Jul; 64(1):54-62. PubMed ID: 24998129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.